Page last updated: 2024-08-21

diphenylamine and Peripheral Nervous System Neoplasms

diphenylamine has been researched along with Peripheral Nervous System Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Aronow, BJ; Brundage, ME; Cripe, TP; Dombi, E; Eaves, D; Giovannini, M; Hardiman Dudley, A; Jessen, WJ; Jousma, E; Kim, MO; Miller, SJ; Niwa-Kawakita, M; Page, GP; Ratner, N; Rizvi, TA; Sabo, J; Widemann, B; Wu, J	1

Trials

1 trial(s) available for diphenylamine and Peripheral Nervous System Neoplasms

Article	Year
MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors. The Journal of clinical investigation, 2013, Volume: 123, Issue:1 Topics: Animals; Benzamides; Child; Child, Preschool; Diphenylamine; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Male; Mice; Mice, Mutant Strains; Mitogen-Activated Protein Kinase Kinases; Neoplasm Transplantation; Neurofibromatosis 1; Oncogene Protein p21(ras); Peripheral Nervous System Neoplasms; raf Kinases; Transcriptome; Transplantation, Heterologous; Xenograft Model Antitumor Assays	2013

Article

Year

MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors.

The Journal of clinical investigation, 2013, Volume: 123, Issue:1

Topics: Animals; Benzamides; Child; Child, Preschool; Diphenylamine; Extracellular Signal-Regulated MAP Kinases; Female; Humans; Male; Mice; Mice, Mutant Strains; Mitogen-Activated Protein Kinase Kinases; Neoplasm Transplantation; Neurofibromatosis 1; Oncogene Protein p21(ras); Peripheral Nervous System Neoplasms; raf Kinases; Transcriptome; Transplantation, Heterologous; Xenograft Model Antitumor Assays

2013